Dear Colleagues:
On behalf of the Editorial Board, we are very pleased to announce that Neurospine will publish a special issue on “Spine and Spinal Cord Tumors” in collaboration with the AANS/CNS Section on Disorders of the Spine and Peripheral Nerves (DSPN, https://www.spinesection.org). The target date for this special issue is March 2022.
We are very excited about partnering with our colleagues at the DSPN for an extraordinary collaboration featuring the latest clinical and research advances in spine oncology. With a shared purpose to advance spine surgery through research and education, we are dedicated to promoting the global exchange of ideas in spinal tumor research and treatment in this special issue.
The call for a special issue on spine and spinal cord tumors is timely. The management of patients with primary and metastatic spinal column tumors is complex and benefits from multidisciplinary communication and collaboration. Each type of tumor that involves the spinal cord and spinal column presents unique surgical and oncologic challenges. With advances in medical and radiation oncology leading to longer survival, spine surgeons are faced with not only improving pain and neurologic function but positively influencing the quality of life of these patients. With any tumor, surgeons need to be mindful of patient frailty, expectations, survival, operative morbidity, and complications.
Surgeons in every type of practice setting around the world are frequently confronted with challenging tumors of the spine and spinal cord. Whether benign or malignant, the decision for surgery as well as the operative strategies required are complex and influenced by resources available in each center. As such, operating on spinal tumors is no longer the exclusive realm of the academic spine surgeon. Surgeons in every type of practice are faced with patients presenting with spine tumor related pain, cord compression and neurological deficits.
With advances in neuro-imaging, neuro-monitoring, medical oncology, radiation oncology, predictive analytics, and data sciences, there has been explosive growth in spine oncology research. Technical innovations using the latest in microsurgery, minimally invasive techniques, robotics, computer-assisted navigation, augmented reality, and biomaterials have equipped surgeons with even more tools to address complex spinal pathology. Although spinal tumors may be difficult to manage, well-planned treatment can achieve excellent outcomes minimizing treatment-related effects. While surgery is the mainstay treatment for many of these tumors, multidisciplinary input is critical as emerging molecular, targeted, and immunotherapies continue to improve survival and complement surgical resection strategies.
The leading editors for this issue include:
Dr. John H. Shin (USA), Dr. Moon-Jun Sohn (Korea), Dr. Toshiki Endo (Japan), Dr. Jau-Ching Wu (Taiwan), and Dr. Khoi D. Than (USA).
Dr. Sun-Ho Lee (Korea), Dr. Martin Stienen (Swiss) and Dr. Chi Heon Kim (Korea).
will play major roles as the Executive Editors.
The editorial team members for this special issue are comprised of expert, world-leading spine tumor surgeons and researchers, who will help to ensure that articles published in this special issue will provide balanced views and evidence-based knowledge to our readers.
 |
 |
 |
Moon-Jun Sohn (Inje Univ., Korea) |
John H Shin (Harvard Univ., USA) |
Toshiki Endo (Tohoku Univ., Japan) |
 |
 |
Jau-Ching Wu (National Yangming Univ., Taiwan) |
Khoi D.Than (Duke Univ., USA) |
 |
 |
 |
Ziya Gokaslan (Brown Univ., USA) |
Daniel M. Sciubba (Hofstra Univ., USA) |
Chun Kee Chung (Seoul National Univ., Korea) |
 |
 |
 |
Yong-Eun Cho (Yonsei Univ., Korea) |
Dean Chou (UC San Francisco, USA) |
Paul Park (Univ. of Michigan, USA) |
 |
 |
 |
Daniel J. Hoh (Univ. of Florida, USA) |
Andrew J Schoenfeld (Harvard Univ., USA) |
John O'Toole (Rush Univ., USA) |
 |
 |
 |
Tsung Hsi Tu (National Yangming Univ., Taiwan) |
Claudius Thomé (Medical Univ. of Innsbruck, Austria) |
Yoshitaka Nagashima (Nagoya Univ., Japan) |
 |
 |
 |
 |
Sun-Ho Lee (Sungkyunkwan Univ., Korea) |
Martin Stienen (Kantonsspital St.Gallen, Swiss) |
Chi Heon Kim (Seoul National Univ., Korea) |
Jin Hoon Park (Asan Medical Center, Korea) |
Requested Article and Video Information
|
Submissions covering any aspect of assessment and treatment for Spine and Spinal Cord Tumors (including peripheral nerve) will be considered. Requested article and video types include:
-Original research, systematic review, and meta-analysis. Potential topics include (but not limited to):
• Novel operative/nonoperative techniques and treatment approaches
• Operative/nonoperative treatment outcomes
• Complications: management approaches and techniques to reduce occurrence
• Novel therapeutic approaches: Surgical or Non-Surgical
• Preoperative planning and patient selection
• Database studies to understand the epidemiology and outcomes
• Quality Benchmarking
• Methods of assessing outcomes: past present and future
• Molecular Biology and markers for understanding the tumorigenesis and prognosis
• Immunotherapy, Gene therapy, Stem cells
• Artificial Intelligence, Machine Learning
• New Diagnostic imaging
• Predictive analytics
-Video articles: case-based or technique-based. Potential topics include (but not limited to):
• Novel surgical approaches/techniques
• Challenging/complex cases
• Applications of new technologies
* Video format instruction:
https://submit.e-neurospine.org/about/How_to_submit_a_video.php
Articles are published upon acceptance, regardless of the publication date of the special issue.
We look forward to receiving high-quality, original work that will advance our knowledge on Spine and Spinal Cord Tumors, provide valuable insights for our readers, and ultimately improve patient outcomes. We want to thank you in advance for helping us make this upcoming issue a success.
Best Regards,
Editor in Chief, Neurospine
Yoon Ha, MD, PhD
Deputy Editors
Wen-Cheng Huang, MD, PhD
Makoto Taniguchi, MD, PhD
Associate Editor
Seung-Jae Hyun MD, PhD
|